New strategy for specific activation of recombinant microbial pro-transglutaminase by introducing an enterokinase cleavage site.
Kun Wang, Bin Wang, Hui-Lin Yang, Li Pan
Index: Biotechnol. Lett. 35(3) , 383-8, (2013)
Full Text: HTML
Abstract
Recombinant microbial transglutaminase (rMTG) is usually expressed as a soluble zymogen (pro-rMTG) in heterologous expression systems but proteolytic activation of the inactive pro-rMTG is essential. Instead of screening proteases for activating pro-rMTG, we examined an alternative method by introducing a specific cleavage site of enterokinase between the pro-peptide and mature rMTG, generating three pro-rMTG variants (Pro-mrMTG, Pro-m-rMTG and mPro-rMTG). Pro-mrMTG and Pro-m-rMTG were activated by enterokinase without degrading mature rMTG. The activation productivity of Pro-m-rMTG by enterokinase reached 92 % after 22 h activation, while the activation productivity of Pro-rMTG activated by trypsin was 47 %. MALDI-MS analysis revealed that the pro-peptide including the cleavage site was specifically removed from Pro-m-rMTG after activation. This methodology has the potential to be applied in rMTG production by incorporating highly specific cleavage sites of other proteases.
Related Compounds
Related Articles:
2014-01-01
[PLoS ONE 9(10) , e109674, (2014)]
2015-12-01
[Appl. Microbiol. Biotechnol. 99 , 10261-9, (2015)]
2015-01-01
[Sci. Rep. 5 , 13093, (2015)]
2015-09-01
[Enzyme Microb. Technol. 77 , 61-7, (2015)]
IL-1 Receptor Antagonist Chimeric Protein: Context-Specific and Inflammation-Restricted Activation.
2015-08-15
[J. Immunol. 195 , 1705-12, (2015)]